Surveillance for Multifocal GGNs
Recruiting
Observational Study
Lung Ground-glass Opacities
Active Surveillance
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 370 (estimated)
- Sponsor
- Fudan University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is a single-arm, multi-center, phase III trial conducted under the Eastern Cooperative Thoracic Oncoloy Project (ECTOP) with the identification number ECTOP-1021. The primary objective of the study is to assess the overall survival of patients with multifocal ground-glass opacities by employing a active surveillance approach rather than opting for surgical resection.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria Patients eligible for enrollment in the study are required to meet all the following criteria.
1. Demonstrates the following on thin-section computed tomography (TSCT) scan:
1. Presence of three or more GGNs (bilateral lesions are permitted).
2. All lesions have remained s…
Contacts